↓ Skip to main content

Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics

Overview of attention for article published in Frontiers in oncology, July 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
twitter
3 X users
patent
3 patents
video
1 YouTube creator

Citations

dimensions_citation
183 Dimensions

Readers on

mendeley
491 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
Published in
Frontiers in oncology, July 2020
DOI 10.3389/fonc.2020.01182
Pubmed ID
Authors

Emily Y. Yang, Khalid Shah

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 491 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 491 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 74 15%
Student > Ph. D. Student 62 13%
Student > Master 56 11%
Researcher 47 10%
Student > Doctoral Student 16 3%
Other 41 8%
Unknown 195 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 133 27%
Chemistry 32 7%
Agricultural and Biological Sciences 26 5%
Pharmacology, Toxicology and Pharmaceutical Science 19 4%
Immunology and Microbiology 16 3%
Other 59 12%
Unknown 206 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2023.
All research outputs
#1,118,604
of 25,791,495 outputs
Outputs from Frontiers in oncology
#187
of 22,802 outputs
Outputs of similar age
#31,779
of 430,500 outputs
Outputs of similar age from Frontiers in oncology
#9
of 526 outputs
Altmetric has tracked 25,791,495 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,802 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,500 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 526 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.